Epigenetic drug target deconvolution by mass spectrometry–based technologies

Research output: Contribution to journalArticlepeer-review


The identification of the full target spectrum of active molecules, known as target deconvolution, has become an indispensable step during the drug discovery process. It is now achievable thanks to mass spectrometry–based technologies. Here we discuss these approaches in the context of epigenetic drug discovery.

Original languageEnglish
Pages (from-to)854-857
Number of pages4
JournalNature Structural and Molecular Biology
Issue number10
Publication statusPublished - Oct 1 2019

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology


Dive into the research topics of 'Epigenetic drug target deconvolution by mass spectrometry–based technologies'. Together they form a unique fingerprint.

Cite this